Roche Holding AG (OTCMKTS:RHHVF – Get Free Report) rose 0.4% during mid-day trading on Wednesday . The stock traded as high as $473.23 and last traded at $466.69. Approximately 61,765 shares traded hands during mid-day trading, an increase of 172% from the average daily volume of 22,688 shares. The stock had previously closed at $465.01.
Roche Stock Performance
The stock has a 50-day moving average of $424.73 and a 200-day moving average of $370.19.
Roche Company Profile
Roche Holding AG, traded on the OTCMKTS under the symbol RHHVF, is a leading global healthcare company with two core business divisions: Pharmaceuticals and Diagnostics. The company focuses on developing innovative medicines and diagnostic tests that address serious diseases, driving advances in personalized healthcare and precision medicine.
In its Pharmaceuticals division, Roche pioneers targeted therapies across oncology, immunology, ophthalmology and neuroscience. Flagship products include monoclonal antibodies and small-molecule treatments such as Herceptin, Avastin and Actemra, which have become standards of care for cancer and autoimmune conditions.
Read More
- Five stocks we like better than Roche
- Trump’s Hand-Written Letter Will Shock his Haters
- ISPC: From Small Cap to Life Sciences Market Disruptor!
- The Crash Has Already Started (Most Just Don’t See It Yet)
- INVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting Off
- Wall Street Legend Names #1 Stock of 2026 Live On-Camera
Receive News & Ratings for Roche Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Roche and related companies with MarketBeat.com's FREE daily email newsletter.
